GB Patent

GB201609603D0 — Polymorphs of N-[(6-cyano-2-fluoro-3-methoxyphenyl)Methyl]-3-(methoxymethyl)-1-({4-[(2-ox opyridin-1-YL)Methyl]phenyl}methyl)pyrazole-4-carboxamide

Assigned to Kalvista Pharmaceuticals Ltd · Expires 2016-07-13 · 10y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number: GB201609603D0
Jurisdiction: GB
Classification: —
Expires: 2016-07-13
Drug substance claim: No
Drug product claim: No
Assignee: Kalvista Pharmaceuticals Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.